Xconomy

JANUARY 11, 2019

[ Editor’s note: Ben Fidler and Sarah de Crescenzo coauthored this report.] It is here, and then it is gone. But by the time everyone staggers to the airport or back home to sleep in their own beds, the annual few days of the J.P. Morgan Healthcare Conference and everything that mushrooms around it seem just as long as the holiday break—a distant memory!—that —that came just before. In 2020 (yes, that’s really a year), San Francisco might have a new mayor.

Pricing 74

Pricing Blogging Report San Diego 74

Berkonomics

JANUARY 26, 2017

Offering too little in an acquisition to satisfy the seller? Email readers, continue here…] There are so many ways to satisfy a seller, sometimes a seller’s ego, by making a price seem higher than the reality of the purchase. You name the price; I’ll name the terms.

Pricing 248

Pricing Sales Tool Competition 248

socalTECH

DECEMBER 7, 2017

San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 odonate therapeutics merger acquisition chemotherapy nasdaq biotech lifescience taxane medical

Pricing 100

Pricing San Diego Capital Funding 100

Xconomy

DECEMBER 10, 2018

The stock price of Mitek (NASDAQ:MITK) rose nearly 9 percent on the news, closing at $9.75. National blog main New York blog main San Diego San Diego blog main San Diego top stories Acquisition ASG Technologies Charles Sansbury deals Elliott fintech hostile takeover M&A Mitek Paul SingerASG Technologies, the Florida-based software company backed by activist hedge fund Elliott Management, has upped its offer for San Diego’s Mitek Systems to $11.50 per share from $10 apiece.

Acquisition 41

Acquisition News Pricing Software 41

socalTECH

APRIL 4, 2017

San Diego-based Tocagen , a clinical stage gene therapy company aiming at treating cancer, has set the pricing range for its IPO. tocagen merger acquisition gene therapy cancer qualcomm jacobsThe company said in a filing that it expects to offer 7,250,000 shares of its common stock at between $10.00 and $12.00 per share. The company has applied to list as TOCA on the NASDAQ Global Market. Tocagen's IPO is being underwritten by Leerink Partners, Evercore ISI, and Stifel.

Pricing 140

Pricing San Diego Marketing Companies 140

socalTECH

MAY 25, 2016

Culver City-based NantHealth , one of the startups out of billionaire Patrick Soon-Shiong's NantWorks portfolio, has set its IPO pricing range at between $12.50 The next step in the IPO process is the company's roadshow to investors and actual pricing of an IPO. nanthealth nantworks merger acquisition pricing personalized medicine

Pricing 109

Pricing Culver City Companies Company 109

socalTECH

OCTOBER 27, 2016

Woodland Hills-based BlackLine Software , the developer of accounting and financial close software, has priced its IPO, saying late Thursday evening that it will sell 8,600,000 shares of its common stock at $17.00 BlackLine priced at the high range of an already increased estimated IPO range, which was set to $16.00 saas software accounting acquisition merger blackline

Pricing 118

Pricing Software Silver Lake Woodland Hills 118

socalTECH

SEPTEMBER 27, 2016

Carlsbad-based Obalon Therapeutics , which is developing a balloon-based medical device for assisting in weight loss, has set the estimated initial IPO pricing range for its public offering, saying it now expects an initial public offering at between $14.00 if it prices at the high end of its estimated range. The company has not yet set an anticipated IPO date, in what has been a busy exits and acquisition year for Southern California's technology companies.

Pricing 143

Pricing .Net Marketing Capital 143

socalTECH

SEPTEMBER 21, 2016

Ventura-based The Trade Desk , which operates an online advertising exchange, priced its IPO late Tuesday evening, saying that it will sell 4,666,677 shares of its Class A common stock at $18.00 The Trade Desk priced at the high end of an already increased estimated IPO range, which had been upped to between $16.00 trade desk pricing merger acquisition advertising exchange market marketplace accelerator incubator nasdaq global

Pricing 149

Pricing Ventura Class Entrepreneur 149

socalTECH

JUNE 11, 2014

La Jolla-based biopharmaceuticals developer Ambrx has set its initial estimated pricing range for its IPO, saying in a filing this morning that it expects to price its IPO at between $12.00 ambrx pricing merger acquisition nasdaq ambx exit biotech lifescience biopharma biopharmaceuticals protein antibody

Pricing 131

Pricing Marketing Capital Develop 131

socalTECH

OCTOBER 25, 2013

Aerie Pharmaceuticals , which develops therapies for treating glaucoma and other eye diseases, has priced its IPO, saying this morning that it is offering up 6,720,000 share os its common stock at $10.00 aerie pharmaceuticals merger acquisition exit lifescience glaucoma

Pricing 163

Pricing Research Marketing Companies 163

socalTECH

MAY 16, 2013

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 Ambit priced well below its estimated initial public offering range, which had been set at between $13.00 ambit biosciences lifescience merger acquisition

Pricing 163

Pricing San Diego Funding Marketing 163

socalTECH

JULY 23, 2018

Santa Barbara-based Sonos , the developer of user-friendly, Internet-connected, whole-home audio systems, set its estimated IPO pricing range on Monday morning, the next step in bringing the company to market. The estimated pricing range is usually set before a company's roadshow to institutional investors, and helps to provide guidance on an ultimate pricing of the IPO, which will occur the evening before the public debut of Sonos.

Pricing 100

Pricing Redpoint Santa Barbara Marketing 100

socalTECH

NOVEMBER 14, 2013

Monrovia, California-based Xencor has set the initial offering price for its IPO, saying in a filing Thursday morning that it will offer up 10,700,000 shares of its common stock at $7.00 The IPO price is below its initial estimated offering price, which had been between $14.00 exit acquisition merger biopharmaceuticals biopharma xencor

Pricing 138

Pricing Monrovia Marketing Technology 138

socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 per share IPO range, after seeing a delay of a week in the expected pricing by the firm.

Pricing 173

Pricing Thousand Oaks Design Marketing 173

socalTECH

JULY 18, 2014

TubeMogul , which develops software to help advertisers with their online video buying, priced its IPO last night, offering up 6,250,000 shares of its common stock at $7.00 tubemogul software digital video advertising merger acquisition exit per share. The company will starts trading this morning on the NASDAQ Global Select Market as TUBE.

Pricing 131

Pricing Capital Marketing Los Angeles 131

socalTECH

MARCH 1, 2017

has officially priced its IPO, saying on Wednesday afternoon that it will sell 200M shares of its common stock at $17.00 Snap's IPO priced above its initial estimated pricing range, which had been between $14.00 snap snapchat merger acquisition exit evan spiegel bobby murphy millionaire billionaireVenice, California-based Snap, Inc. per share. The IPO will raise $3.4 billion for Snap, the company behind Snapchat , valuing the company at approximately $24 billion.

Pricing 131

Pricing Venice Capital Technology 131

socalTECH

SEPTEMBER 20, 2016

In a sign that reception to the company's IPO is going well, Ventura-based The Trade Desk said in a regulatory filing on Monday that it now expects its initial public offering price to be between $16.00 accelerator marketplace market exchange advertising acquisition merger pricing desk trade

Pricing 125

Pricing Ventura Companies Company 125

socalTECH

AUGUST 4, 2014

San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. Setting and estimated IPO pricing range is one of the activites which leads up to a company''s IPO, and generally occurs as the company embarks on a road show to insitutional investors. otonomy biopharmaceuticals biotech lifescience merger acquisition inner disease exit otic pricing

Pricing 131

Pricing Avalon San Diego Marketing 131

socalTECH

MARCH 14, 2014

San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 ignyta biotech lifescience merger acquisition cancer a share. The IPO will raised $48.0M for the company. Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today. Ignyta''s offering was run by Leerink Partners and Ladenburg Thalman & Co. Ignyta is a precision medicine company targeting treatment for cancer.

Pricing 125

Pricing San Diego Marketing Capital 125

socalTECH

DECEMBER 3, 2013

Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 xencor biopharma biopharmaceuticals merger acquisition exit lifescience per share, and will start trading today on the NASDAQ Global Market as XNCR. Xencor sold 12,730,000 shares of its common stock in the IPO. Xencor was venture backed by MedImmune Ventures, HealthCare Ventures, and others. READ MORE>>.

Pricing 125

Pricing Monrovia Marketing Develop 125

Xconomy

NOVEMBER 5, 2018

The purchase price is 25 times MatrixCare’s pro forma 2018 earnings of about $30 million (without taking into account interest, taxes, depreciation or amortization) on anticipated net revenue of about $122 million.

Acquisition 89

Acquisition .Net Software Pricing 89

socalTECH

FEBRUARY 5, 2014

La Jolla-based biopharmaceuticals developer Auspex Pharmaceuticals has priced its IPO, saying it will offer up 7,000,000 shares of its common stock at $12.00 auspex pharmaceuticals merger acquisition lifescience healthcare huntington movement disorder tourette tardive dyskinesia per share. The company will begin trading this morning as ASPX on the NASDAQ Global Market. Auspex is developing treatments for Huntington''s and other orphan diseases.

Pricing 125

Pricing Capital Marketing Companies 125

socalTECH

JUNE 27, 2017

NantCell said the price is a "significant premium" to recent equity financings. Soon-Shiong and NantCell recently was sued by investors over the "lowball" initial pricing on the deal. nantcell altor bioscience merger acquisition nantworks patrick soon shiong biotech lifescienceCulver City-based NantCell , one of the companies that is part of Dr. Patrick Soon-Shiong's NantWorks group of companies, is acquiring Altor Bioscience. The deal is worth approximately $290M.

Acquisition 109

Acquisition Culver City Pricing Equity 109

socalTECH

OCTOBER 17, 2016

Woodland Hills-based accounting software maker BlackLine Systems has moved one step closer to its IPO, saying this morning in a regulatory filing that it is expecting its IPO to price at betwen $13.00 blackline systems merger acquisition finance accounting software saas close financial fintech

Silver Lake 131

Silver Lake Pricing Woodland Hills CTO 131

socalTECH

MAY 2, 2017

billion price tag. veritone merger acquisition chad ryan steelberg dmarc broadcasting veri exit acaciaresNewport Beach-based Veritone , a developer of cloud-based, artificial intelligence software, says it expects its IPO to be between $14.00 and $16.00 per share, as it launches its roadshow. Veritone is looking to list as VERI on the NASDAQ Capital Market and hopes to raise as much as $20M in its IPO effort.

Pricing 116

Pricing Google Research Capital 116

socalTECH

NOVEMBER 2, 2017

SendGrid , the developer of email delivery tools and back-end email services with operations in Irvine, has set its estimated IPO pricing range this morning, saying it is looking to sell 7,700,000 shares of its common stock at between $13.50 sendgrid merger acquisition send email delivery service server isaac saldana irvine

Pricing 100

Pricing Orange County Tool Capital 100

socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The IPO follows one of the most active IPO and mergers and acquisitions years for Southern California last year, in 2016, and comes ahead of an anticipated IPO announcement for Venice-based Snap, Inc. anaptysbio executive biotech lifescience inflammation merger acquisition snapchat exi

Pricing 109

Pricing Avalon Venice San Diego 109

socalTECH

AUGUST 11, 2017

Earlier reports had placed the acquisition of Zenly at between $250M to $350M. snap snapchat zenly merger acquisition social networking media locationLos Angeles-based Snap Inc. paid $213.3M in cash for Zenly , the developer of a location-based social media app, in May, the company disclosed in its quarterly results on Thursday. Snap said it paid $196.1M in purchase consideration, including $186.8M in cash paid to sellers, $9.3M in liabilities due to sellers, and $17.2M

Pricing 109

Pricing Social Media Report Los Angeles 109

socalTECH

NOVEMBER 14, 2013

San Diego-based medical device manufacturer Tandem Diabetes Care priced its IPO last night, saying it will offer up 8,000,000 shares of its common stock at $15.00 tandem diabetes care diabetic medical device exit merger acquisition tndm per share. The company--which develops an insulin pump--will start trading today on the NASDAQ Global Market as TNDM.

Pricing 135

Pricing San Diego Marketing Develop 135

socalTECH

FEBRUARY 8, 2012

Thousand Oaks-based Ceres , the developer of seeds for producing renewable bioenergy feedstocks, has cut its estimated IPO pricing range, ahead of its anticipated IPO this week. In an updated S-1, Ceres now estimates that it will price at between $16.00

Pricing 158

Pricing Thousand Oaks Develop Development 158

socalTECH

NOVEMBER 4, 2013

Monrovia, California-based Xencor , the biopharmaceuticals technology developer headed by Bassil Dahiyat, has set its IPO pricing range, saying today in a regulatory filing that it is expecting to price its IPO at between $14.00 xencor biopharma biopharmaceuticals merger acquisition exit

Pricing 125

Pricing Monrovia Marketing Technology 125

socalTECH

JUNE 30, 2016

No pricing details on the potential deal--which the Journal said "may not result in a deal"--were released. tidal music apple computer merger acquisition rumor streaming jayzA report from the WSJ late Thursday said that Apple Computer is in discussions with music service Tidal --founded by Jay-Z--to acquire the company. READ MORE>>.

Acquisition 109

Acquisition Journal Pricing Report 109

socalTECH

SEPTEMBER 7, 2016

Ventura-based The Trade Desk has set the initial estimated pricing range for its IPO, saying in a filing on Tuesday that it now expects its IPO to be between $14.00 trade desk tradedesk merger acquisition advertisingand $16.00 per share. The company is selling 4,666,667 shares of its common stock in the offering. The Trade Desk has applied to list on the NASDAQ Global Market as TTD. The Trade Desk operates an online advertising exchange. READ MORE>>.

Pricing 109

Pricing Ventura Marketing Companies 109

socalTECH

OCTOBER 11, 2012

Calabasas-based KYTHERA Biopharmaceuticals , a developer of aesthetic medicine products aimed at reducing fat deposits, has priced its IPO at $16.00 The firm priced at the high end of its estimated initial public offering range, which was between $14.00 kythera biopharmaceuticals biotech medicine reduction merger acquisition exitper share. The firm is offering 4,400,000 shares of its common stock on the NASDAQ Global Select Market as KYTH.

Pricing 116

Pricing Calabasas Marketing Product 116